Diet pills - a wonder drug for the waistline or a waste of money? Find out here about how weight loss pills work and their side effects.
Why am I overweight? In this video we examine what causes obesity and its connection to hypothyroidism.
How do I find out if I’m overweight? Watch this video and find out if you have a healthy weight by learning how to calculate your BMI.
How can I lose weight? There are so many tips and places where I can get advice. Which ones really work to help lose a few pounds? Watch this video to find out.
Where can I get weight loss help? Can I do it with dieting alone? Watch this video and find out the help available to you.
Struggling to lose weight? Find out about weight loss drugs and treatments here.
Is a cure for type II diabetes on the horizon? Could surgery be the answer? Watch this video to learn more about bariatric surgery.
The National Institute for Clinical excellence (NICE) and the National Obesity Forum (NOF) both recommend pharmacotherapy (obesity drugs such as lipase inhibitors) to help with weight loss where appropriate. This includes patients who either:
• Have not been successful with a weight management programme based around lifestyle, exercise or nutrition advice
• Are considered at such a high risk for the co-morbidities of obesity that they need to lose weight more rapidly than by traditional methods alone
The following weight loss drugs and treatments are available:
Orlistat is part of a group of obesity drugs called lipase inhibitors. It works by reducing the amount of fat that is absorbed into the body. (“Lipase” means fat) 1/3 of the fat consumed by food is not absorbed and turned into calories whilst taking this obesity medication.
If a patient has a stable weight prior to taking obesity drugs such as Orlistat then using this obesity medication will allow them to lose weight.
However, if a patient taking Orlistat eats a diet high in fat then they will experience side effects, including yellow diarrhea; painful flatulence; oily stools; and in extreme cases faecal incontinence. These side effects are not from the obesity medication but from the high-fat diet. For this reason, patients need to be counselled by a healthcare professional to eat a low fat diet, reducing the risk of side effects with Orlistat and other lipase inhibitors.
A recent European licence has been granted for a lower dose of 60mg of Orlistat available over the counter from the pharmacist. However, this obesity medication is not available to simply pick up and purchase. There will still be a structured weight management programme put in place, which will be managed by the pharmacist.
The advantage for the patient is that they do not have to visit their GP to get a weight reducing drug. It is the first time that an obesity medication will be available over the counter in the UK.
Sibrutramine , also known as Reductil, is an alternative weight reducing drug. Sibrutramine acts centrally on parts of the brain to make the patient feel fuller. During the first few weeks of taking this obesity medication there is a risk that a patient’s blood pressure can rise, which is why a GP will want to see any patient taking sibrutamine on fortnightly visits to check their blood pressure remains within normal limits whilst taking the obesity medication.
Warning: The European Medicines Agency has recommended that sales of sibutramine be suspended due to links to an increased risk of cardiovascular events. Read more.
Dr Matthew Capehorn, Obesity Specialist
Chairman of the Yorkshire and the Humber region of the National Obesity Forum
10045 Revised November 2012comments powered by Disqus